This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Glover, D. K. Articles by Okada, R. D. Search for Related Content PubMed PubMed Citation Articles by Glover, D. K. Articles by Okada, R. D.

Circulation, Vol 81, 628-637, Copyright © 1990 by American Heart Association

ARTICLES

Myocardial kinetics of Tc-MIBI in canine myocardium after dipyridamole

DK Glover and RD Okada
Saint Francis Hospital Medical Research Institute, Cardiology of Tulsa, Oklahoma 74136.

Technetium 99m-hexakis-2-methoxy-2-methylpropyl-isonitrile (Tc-MIBI) is a promising new myocardial perfusion imaging agent producing excellent rest images. Imaging, however, will need to be performed with exercise or dipyridamole to detect ischemia and to differentiate salvaged but still ischemic myocardium from scar. Accordingly, 12 dogs were given mild-to-moderate left circumflex coronary stenoses (group 2), and 10 dogs were given severe stenoses (group 3). In five control dogs (group 1), there was no stenosis. After an intravenous infusion of dipyridamole (0.08 mg/kg/min for 4 minutes), Tc-MIBI was injected into the right atrium. Over the next 4-hour study period, myocardial Tc-MIBI activities were continuously monitored in both the left anterior descending (LAD) (normal) and left circumflex (LCx) (ischemic) coronary artery (ischemic) zones using miniature cadmium telluride radiation detectors and serial gamma camera images were acquired when necessary. Tc-MIBI was rapidly taken up by nonischemic, mild-to-moderate, and severe ischemic myocardium. The initial myocardial uptake of Tc-MIBI was linearly related (r = 0.97) to regional myocardial blood flow at rates up to 2.0 ml/min/g. After the initial uptake, the mean 4-hour fractional myocardial clearance was similar between the control (0.09 +/- 0.03 [+/- SEM]) and group 2 (0.07 +/- 0.03) and group 3 (0.09 +/- 0.03) ischemic zones. Tc-MIBI blood clearance was rapid and biexponential with an initial fast clearance phase followed by a slow clearance phase.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				E. Croteau, F. Benard, M. Bentourkia, J. Rousseau, M. Paquette, and R. Lecomte Quantitative Myocardial Perfusion and Coronary Reserve in Rats with 13N-Ammonia and Small Animal PET: Impact of Anesthesia and Pharmacologic Stress Agents J. Nucl. Med., November 1, 2004; 45(11): 1924 - 1930. [Abstract] [Full Text] [PDF]

				F. J. Klocke, O. P. Simonetti, R. M. Judd, R. J. Kim, K. R. Harris, S. Hedjbeli, D. S. Fieno, S. Miller, V. Chen, and M. A. Parker Limits of Detection of Regional Differences in Vasodilated Flow in Viable Myocardium by First-Pass Magnetic Resonance Perfusion Imaging Circulation, November 13, 2001; 104(20): 2412 - 2416. [Abstract] [Full Text] [PDF]

				J. Taki, S. Fujino, K. Nakajima, I. Matsunari, H. Okazaki, T. Saga, H. Bunko, and N. Tonami 99mTc-Sestamibi Retention Characteristics During Pharmacologic Hyperemia in Human Myocardium: Comparison with Coronary Flow Reserve Measured by Doppler Flowire J. Nucl. Med., October 1, 2001; 42(10): 1457 - 1463. [Abstract] [Full Text] [PDF]

				K. Wei, E. Le, J.-P. Bin, M. Coggins, A. R. Jayawera, and S. Kaul Mechanism of reversible 99mTc-sestamibi perfusion defects during pharmacologically induced vasodilatation Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1896 - H1904. [Abstract] [Full Text] [PDF]

				P. G. Danias Stress testing and electron beam computed tomography for evaluation of patients with suspected coronary artery disease J. Am. Coll. Cardiol., January 1, 2001; 37(1): 334 - 335. [Full Text] [PDF]

				H. A. Skopicki, S. A. Abraham, M. H. Picard, N. M. Alpert, A. J. Fischman, and H. Gewirtz Effects of Dobutamine at Maximally Tolerated Dose on Myocardial Blood Flow in Humans With Ischemic Heart Disease Circulation, November 18, 1997; 96(10): 3346 - 3352. [Abstract] [Full Text]

				D. K. Glover, M. Ruiz, J. Y. Yang, W. H. Smith, D. D. Watson, and G. A. Beller Myocardial 99mTc-Tetrofosmin Uptake During Adenosine-Induced Vasodilatation With Either a Critical or Mild Coronary Stenosis : Comparison With 201Tl and Regional Myocardial Blood Flow Circulation, October 7, 1997; 96(7): 2332 - 2338. [Abstract] [Full Text]

				D. K. Glover, M. Ruiz, J. Y. Yang, B. A. Koplan, T. R. Allen, W. H. Smith, D. D. Watson, R. J. Barrett, and G. A. Beller Pharmacological Stress Thallium Scintigraphy With 2-Cyclohexylmethylidenehydrazinoadenosine (WRC-0470): A Novel, Short-Acting Adenosine A2A Receptor Agonist Circulation, October 1, 1996; 94(7): 1726 - 1732. [Abstract] [Full Text]

				V. Sansoy, D. K. Glover, D. D. Watson, M. Ruiz, W. H. Smith, J. P. Simanis, and G. A. Beller Comparison of Thallium-201 Resting Redistribution With Technetium-99m–Sestamibi Uptake and Functional Response to Dobutamine for Assessment of Myocardial Viability Circulation, August 15, 1995; 92(4): 994 - 1004. [Abstract] [Full Text]

				D. K. Glover, M. Ruiz, N. C. Edwards, M. Cunningham, J. P. Simanis, W. H. Smith, D. D. Watson, and G. A. Beller Comparison Between 201Tl and 99mTc Sestamibi Uptake During Adenosine-Induced Vasodilation as a Function of Coronary Stenosis Severity Circulation, February 1, 1995; 91(3): 813 - 820. [Abstract] [Full Text]